Since there is a 0.2% incidence of death due to pneumonitis in patients treated with checkpoint inhibitors [78], the mortality rate after PD-1/PD-L1 inhibition may increase in IPF patients. Here, CD274 is linked to idiopathic pulmonary fibrosis.